Lv4
500 积分 2024-07-09 加入
Gene editing treats a mouse model of a neurodevelopmental disorder
30天前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
4个月前
已完结
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
4个月前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
4个月前
已完结
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial
4个月前
已完结
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial
5个月前
已完结
[Expert consensus on the management of adverse events of CDK4/6 inhibitors in breast cancer]
8个月前
已完结
Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer
10个月前
已完结
The Proposed 9th Edition TNM Classification of Lung Cancer
11个月前
已完结
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer
11个月前
已完结
皖公网安备34019202002308
